Following multibillion dollar asset acquisitions and artificial intelligence (AI)-centred deals, Servier’s head of business development outlines how one of France’s…
The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory building, but by a broader statement of intent about Europe’s…
For years, Serena Williams was the defining face of women’s tennis. Now, her ongoing alliance with a telehealth company may be signifying a broader shift in US healthcare advertising, reflecting…
June was a busy month for Pharmaceutical Technology’s editorial team, with journalists attending several key conferences with reach across the healthcare and life science sectors. This includes the BIO International…
On 21 May 21, 2026, Eli Lilly’s retatrutide achieved a historic first; as of June 2026, it is the only drug to produce an average weight loss above 30% in…
As healthcare players from Europe and further afield continue to produce potentially game-changing healthcare innovations, attendees at HLTH Europe 2026 turned their attention to how these technologies, pharmaceutical products and…
Upon its rise to notoriety spearheaded by drugs like Novartis’ Pluvicto (lutetium Lu 177 vipivotide tetraxetan), the radiopharmaceutical field is capturing the attention of both industry and investors, as the…
